Sherlock Biosciences Announces Research Collaboration with Dartmouth-Hitchcock Health to Launch Study of CRISPR-based Test for SARS-CoV-2
Sherlock Biosciences and Dartmouth-Hitchcock Health will launch a clinical study of the Sherlock CRISPR SARS-CoV-2 kit for the detection of the novel coronavirus that causes COVID-19. The kit is the first and only CRisPR-based diagnostic test to receive EUA from the FDA for qualitative detection of nucle acid from SARS.
Because Being In The Same Room Is Better Than Being On The Same Zoom!

@ the Oakland Marriott City Center, Oakland CA